Chemed (NYSE:CHE) CEO Sells $1,079,020.00 in Stock

Chemed Corporation (NYSE:CHEGet Free Report) CEO Kevin Mcnamara sold 2,000 shares of the stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the transaction, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at approximately $37,991,215.18. This trade represents a 2.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Chemed Price Performance

Chemed stock opened at $549.01 on Friday. The company’s 50 day simple moving average is $475.46 and its 200-day simple moving average is $439.05. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $551.74. The company has a market capitalization of $7.18 billion, a price-to-earnings ratio of 27.57, a price-to-earnings-growth ratio of 2.07 and a beta of 0.51.

Chemed (NYSE:CHEGet Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. The firm had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter last year, the firm earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities research analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.4%. The ex-dividend date was Thursday, May 28th. Chemed’s payout ratio is currently 12.05%.

Institutional Investors Weigh In On Chemed

Several large investors have recently bought and sold shares of the stock. Abbot Financial Management Inc. acquired a new stake in Chemed in the 2nd quarter valued at about $559,000. Global Retirement Partners LLC acquired a new position in shares of Chemed during the second quarter worth about $49,000. Bank of New York Mellon Corp purchased a new stake in shares of Chemed during the second quarter worth approximately $43,800,000. Focus Partners Advisor Solutions LLC acquired a new stake in Chemed in the second quarter valued at approximately $998,000. Finally, State of Wyoming acquired a new stake in Chemed in the second quarter valued at approximately $151,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CHE shares. Royal Bank Of Canada raised their target price on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. Oppenheimer raised their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Finally, Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $530.75.

Get Our Latest Report on Chemed

Chemed Company Profile

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Featured Articles

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.